Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON51962
NL-OMON51962
Recruiting
Phase 2

Phase II non-randomized study on proton radiotherapy of thymic malignancies - PROTHYM

Swedish Lung Cancer Study Group0 sites10 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionscancerThymoma10027655

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
cancer
Sponsor
Swedish Lung Cancer Study Group
Enrollment
10
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Swedish Lung Cancer Study Group

Eligibility Criteria

Inclusion Criteria

  • •\- Histological or cytological diagnosis of thymoma or thymic carcinoma
  • •\- With radical surgery stage III, IV and selected stage II with type B2, B3 or
  • •thymic carcinoma according to local routine
  • •\- With non\-radical surgery (R1 or R2\), stage I \- IVa, any histology
  • •\- Medically inoperable or patient refusing surgery, stage I \- IVa, any histology
  • •\- PS WHO 0\-2
  • •\- FEV1 \>/1l or \>/40% of predicted and CO diffusion capacity \>40% of predicted
  • •(post\-operative measures)
  • •\- Age \>/18 years, no upper age limit
  • •\- Written informed consent

Exclusion Criteria

  • •\- Masoaka\-Koga stage IVb (distant metastases)
  • •\- Pregnancy
  • •\- Serious concomittant systemic disorder incompatible with the study
  • •\- Tumour motion \>0,5cm on two repeated 4DCT

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
A Prospective Clinical Trial of Proton Radiotherapy with 12 fractions for Patients with Prostate CancerProstate cancer
JPRN-UMIN000045064arita Memorial Proton Center200
Not yet recruiting
Phase 2
Study of Chlorophllin for reducing chemotherapy and radiotherapy treatment side effects in head and neck cancersHealth Condition 1: C139- Malignant neoplasm of hypopharynx,unspecifiedHealth Condition 2: C119- Malignant neoplasm of nasopharynx,unspecifiedHealth Condition 3: C109- Malignant neoplasm of oropharynx,unspecifiedHealth Condition 4: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
CTRI/2023/07/055047Tata Memorial Hospital
Completed
Not Applicable
A clinical trial of proton radiotherapy with local immunotherapy for recurrent cases with hepatocellular carcinoma
JPRN-UMIN000002863Proton Medical Research Center, University of Tsukuba10
Recruiting
Not Applicable
Study on Proton Radiotherapy of Thymic MalignanciesCardiotoxicityPulmonary ToxicityThymus Neoplasms
NCT04822077Ass. Prof. Jan Nyman40
Active, not recruiting
Phase 1
A study to investigate the effect of addition of metformin to standard treatment in patients with inoperable stage III non-small cell lung cancer.
EUCTR2017-004877-15-BEAntwerp University Hospital, Department Thoracic Oncology104